Chemoinformaics analysis of 2,2-Diethyl-N-ethylpyrrolidine
| Molecular Weight | 155.285 | nRot | 3 |
| Heavy Atom Molecular Weight | 134.117 | nRig | 5 |
| Exact Molecular Weight | 155.167 | nRing | 1 |
| Solubility: LogS | -2.356 | nHRing | 1 |
| Solubility: LogP | 3.151 | No. of Aliphatic Rings | 1 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 1 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 32 | No. of Aliphatic Hetero Cycles | 1 |
| No. of Heavy Atom | 11 | No. of Aromatic Carbocycles | 0 |
| nHetero | 1 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 21 | No. of Saturated Hetero Cycles | 1 |
| No. of Carbon atom | 10 | No. of Saturated Rings | 1 |
| No. of Nitrogen atom | 1 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 0 | No. of Arom Bond | 0 |
| nHA | 1 | APOL | 31.8027 |
| nHD | 0 | BPOL | 22.7773 |
| QED | 0.605 |
| Synth | 3.065 |
| Natural Product Likeliness | 0.188 |
| NR-PPAR-gamma | 0.004 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Accepted |
| Golden Triangle | Rejected |
| Pgp-inh | 0.001 |
| Pgp-sub | 0.148 |
| HIA | 0.003 |
| CACO-2 | -4.494 |
| MDCK | 0.0000111 |
| BBB | 0.98 |
| PPB | 0.422579 |
| VDSS | 2.082 |
| FU | 0.665855 |
| CYP1A2-inh | 0.055 |
| CYP1A2-sub | 0.921 |
| CYP2c19-inh | 0.047 |
| CYP2c19-sub | 0.954 |
| CYP2c9-inh | 0.005 |
| CYP2c9-sub | 0.244 |
| CYP2d6-inh | 0.796 |
| CYP2d6-sub | 0.895 |
| CYP3a4-inh | 0.011 |
| CYP3a4-sub | 0.368 |
| CL | 11.16 |
| T12 | 0.308 |
| hERG | 0.042 |
| Ames | 0.026 |
| ROA | 0.889 |
| SkinSen | 0.622 |
| Carcinogencity | 0.935 |
| EI | 0.789 |
| Respiratory | 0.986 |
| NR-Aromatase | 0.005 |
| Antiviral | No |
| Prediction | 0.898617 |